Becton, Dickinson and Company (BDX) vs Repligen Corporation (RGEN)
- Becton, Dickinson and Company BDX 191.75 −1.04%
- Repligen Corporation RGEN 175.20 −4.87%
Becton, Dickinson and Company and Repligen Corporation are both Medical Instruments & Supplies companies. Becton, Dickinson and Company is the larger, with a market value of $52.8B against $11.7B — 4.5× the size. Becton, Dickinson and Company trades at the lower P/E: 57.8× against 234×. Repligen Corporation grew revenue faster over the last twelve months: 16.5% against 13.1%. Repligen Corporation has the higher net margin (5.29% vs 4.20%) and the lower return on invested capital (2.18% vs 3.89%). Across the 22 metrics below, Becton, Dickinson and Company leads on 14 and Repligen Corporation on 8.
Valuation
Profitability
| Metric | BDX | RGEN | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 46.73% | 53.52% | 54.29% |
| Operating margin | 10.30% | 8.23% | 1.07% |
| Net margin | 4.20% | 5.29% | (1.61%) |
| Free cash flow margin | 14.29% | 14.06% | 1.08% |
| Return on equity | 3.77% | 1.99% | (1.32%) |
| Return on assets | 1.78% | 1.42% | 0.00% |
| Return on invested capital | 3.89% | 2.18% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack